Janux Therapeutics, Inc. - Common Stock - relatórios financeiros (NASDAQ:JANX) | MetaTrader

Abrir gráfico completo Full chart

Notícias

Wall Street Analysts Predict a 155.82% Upside in Janux Therapeutics (JANX): Here's What You Should Know

Here's Why You Should Add JANX Stock to Your Portfolio Now

VP da Janux Therapeutics vende US$ 28.878 em ações

Janux Therapeutics, Inc. (JANX) Reports Q1 Loss, Lags Revenue Estimates

How Much Upside is Left in Janux Therapeutics (JANX)? Wall Street Analysts Think 180.44%

Undercovered Stocks: Western Digital, SAP, Toast And More

Janux Therapeutics: Strong Buy As Pipeline Advances, Stock Trades Below Cash Value (JANX)

BofA reduz preço-alvo da Janux Therapeutics após mudanças no pipeline

Janux descontinua desenvolvimento de terapia contra câncer direcionada ao EGFR

Bristol-Myers Squibb: 'Strong Buy' As 2026 Milestones Could Bolster Its Prospects (NYSE:BMY)

H.C. Wainwright reitera classificação de compra para ações da Janux Therapeutics

Will Acute Care Strength Help Universal Health Offset Q1 Rising Costs?